60 Degrees Pharmaceuticals vs Traws Pharma
SXTP and TRAW side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How SXTP and TRAW compare
Traws Pharma is the larger company, worth 2.1 times as much as 60 Degrees Pharmaceuticals ($3.9M against $1.8M).
60 Degrees Pharmaceuticals scores higher on the StockData Score (8 against 5 for Traws Pharma), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | SXTP | TRAW |
|---|---|---|
| Size and price | ||
| Market cap | $1.8M | $3.9M |
| Share price | $0.518 | $0.251 |
| Change, 1 year | −89.5% | −88.3% |
| Change, 5 years | – | −99.7% |
| Beta (5Y) | 2.09 | 1.19 |
| Employees | 3 | 7 |
| StockData Score | ||
| Total score | 8 (better) | 5 |
| Valuation score | 3 (better) | 0 |
| Growth score | 2 (better) | 1 |
| Performance score | 1 (better) | 0 |
| Health score | 2 | 4 (better) |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 1.6× | – |
| P/B | 0.7× | – |
| FCF yield | −488% | – |
| Fair value | $1.29 | – |
| Margin of safety | 59.7% | – |
| Growth | ||
| Revenue growth (TTM) | 73.2% | – |
| Revenue growth, 5Y average | – | 64.6% |
| Profitability | ||
| Gross margin | 19.4% | – |
| Operating margin | −775% | – |
| Net margin | −730% | – |
| FCF margin | −801% | – |
| Return on equity | −322% | – |
| Return on invested capital | −659% | – |
| Financial health | ||
| Debt / equity | 0.00 | – |
| Interest coverage | −1134.8× | – |
| Current ratio | 2.32 (better) | 0.93 |
| Altman Z-score | −22.23 (better) | −85.39 |
| Piotroski F-score | 2 | 4 (better) |
| Dividends and buybacks | ||
| Buyback yield | – | −109% |
| Shareholder yield | 0.00% (better) | −109% |
| Ownership | ||
| Held by institutions | 21.5% | 40.1% |
| Held by insiders | 21.0% | 35.7% |
| Insider net buying, 12 months | $30.1K | $998K (better) |
| Short interest, % of float | – | 6.9% |
Go deeper
- SXTP stock overview
- SXTP income statement
- SXTP valuation and score
- TRAW stock overview
- TRAW income statement
- TRAW valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.